ResMed Inc. Reports FY2026 Results; Raises Quarterly Dividend 10%

What Happened

• ResMed (RMD) filed a Form 8‑K on August 6, 2026 furnishing a press release (Exhibit 99.1) that describes the company's results of operations for the quarter and fiscal year ended June 30, 2026.
• On the same day the board declared a quarterly cash dividend of US $0.66 per share, a 10% increase versus the prior quarterly dividend (from $0.60). The dividend is payable September 24, 2026, to shareholders of record on August 20, 2026 (ex‑dividend date August 19, 2026).

Key Details

• Press release filed: August 6, 2026 (Exhibit 99.1) covering quarterly and fiscal year results (quarter and FY ended June 30, 2026).
• Dividend: $0.66 per common share (10% increase); record date Aug 20, 2026; ex‑dividend date Aug 19, 2026; payment date Sep 24, 2026.
• Currency/ADR notes: NYSE common stockholders receive the dividend in US dollars; holders of CHESS Depositary Interests (CDIs) on the ASX receive the Australian dollar equivalent based on the exchange rate on the record date, reflecting the 10:1 CDI:share ratio.
• ASX operational note: ResMed received a waiver to defer processing conversions between common stock and CDI registers from Aug 19–20, 2026 (inclusive).

Why It Matters

• The furnished press release contains ResMed’s reported quarterly and fiscal-year financial results (revenue, earnings, and other operating metrics) that can materially affect the stock; investors should read the press release for the specific earnings and guidance figures.
• The 10% dividend increase signals management’s decision to raise cash returns to shareholders and will affect yield and near-term cash flows for income investors. Pay/record/ex‑dividend dates determine which holders qualify for the payment, and the ASX waiver affects conversion timing for CDI holders.